GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Cash From Other Investing Activities

VACBF (Nykode Therapeutics AS) Cash From Other Investing Activities : $8.26 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Nykode Therapeutics AS's cash from other investing activities for the three months ended in Sep. 2024 was $1.09 Mil. It means Nykode Therapeutics AS received $1.09 Mil from other investing activities. Nykode Therapeutics AS's cash from other investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was $8.26 Mil.

Nykode Therapeutics AS Cash From Other Investing Activities Historical Data

The historical data trend for Nykode Therapeutics AS's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Cash From Other Investing Activities Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash From Other Investing Activities
Get a 7-Day Free Trial 0.04 0.01 0.27 3.68 8.94

Nykode Therapeutics AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.56 0.09 2.53 1.09

Nykode Therapeutics AS Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nykode Therapeutics AS Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Cash From Other Investing Activities
Comparable Companies
OSL:ULTI OSL:AZT OSL:HBC OSL:BGBIO OSL:CIRCA OSL:EXTX OSL:TRMED OSL:LYTIX OSL:ABS OSL:PCIB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NYKD:Norway 5VB:Germany
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Website
https://www.nykode.com
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.